WBI Investments’s iShares Biotechnology ETF IBB Stock Holding History

WBI Investments’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-16,638	Closed	-$1.83M	–	284
2018 Q2	$1.83M	Buy	+16,638	New	+$1.78M	0.1%	136
2017 Q3	–	Sell	-22,287	Closed	-$2.3M	–	326
2017 Q2	$2.3M	Buy	+22,287	New	+$2.2M	0.1%	143

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WBI Investments's IBB Position: Q3 2018 in Review

WBI Investments sold out of iShares Biotechnology ETF (IBB) in Q3 2018, closing a stake of 16,638 shares — an estimated $1.83M sold.

WBI Investments first reported a position in IBB in Q2 2017 and held it in 2 quarters. The position peaked at $2.3M in Q2 2017. 631 funds tracked by Wall St. Rank hold IBB as of Q3 2018.

WBI Investments reported no remaining iShares Biotechnology ETF position as of Q3 2018 after selling out during the quarter.
WBI Investments sold 16,638 iShares Biotechnology ETF shares in Q3 2018, an estimated $1.83M.
WBI Investments first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 2 quarters.
WBI Investments's iShares Biotechnology ETF position peaked at $2.3M in Q2 2017.
631 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2018.

Based on WBI Investments's 13F filing for Q3 2018, filed 31 Oct 2018.